MRI of cardiac morphology and function after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.

OBJECTIVE The objective of our study was to use MRI to show the cardiac morphology and function of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation. CONCLUSION Black blood T2-weighted and contrast-enhanced fast inversion recovery gradient-echo images displayed ablated septal myocardium until 35 weeks after percutaneous transluminal septal myocardial ablation. Central hypointense areas were observed on MRI in patients until 4 weeks after ablation. Black blood and cine steady-state free precession MRI were used to assess the decreased septal wall thickness and diameter of the left atrium after ablation as well as the reduced motion of the ablated region. MRI may be useful for evaluation of cardiac structural, signal, and functional changes associated with percutaneous transluminal septal myocardial ablation.

[1]  R. Bonow,et al.  Hypertrophic cardiomyopathy. , 1987, Disease-a-month : DM.

[2]  P. V. van Dijkman,et al.  Follow-up of regional myocardial T2 relaxation times in patients with myocardial infarction evaluated with magnetic resonance imaging. , 1990, European journal of radiology.

[3]  C. Higgins,et al.  Interstudy reproducibility of dimensional and functional measurements between cine magnetic resonance studies in the morphologically abnormal left ventricle. , 1990, American heart journal.

[4]  U. Sigwart.  Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy , 1995, The Lancet.

[5]  V. Poutanen,et al.  Right and left atrial phasic volumetric function in mildly symptomatic dilated and hypertrophic cardiomyopathy: cine MR imaging assessment. , 1996, Radiology.

[6]  O. Simonetti,et al.  "Black blood" T2-weighted inversion-recovery MR imaging of the heart. , 1996, Radiology.

[7]  D. Fassbender,et al.  Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients. , 1998, Journal of the American College of Cardiology.

[8]  Katherine C. Wu,et al.  Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. , 1998, Circulation.

[9]  H. Kuhn,et al.  Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy. , 1999, European heart journal.

[10]  J. Schulz-Menger,et al.  The value of magnetic resonance imaging of the left ventricular outflow tract in patients with hypertrophic obstructive cardiomyopathy after septal artery embolization. , 2000, Circulation.

[11]  O. Simonetti,et al.  Cine MR angiography of the heart with segmented true fast imaging with steady-state precession. , 2001, Radiology.

[12]  D. Pennell,et al.  Images in cardiovascular Medicine. Magnetic resonance contrast enhancement of iatrogenic septal myocardial infarction in hypertrophic cardiomyopathy. , 2002, Circulation.

[13]  Y. Amano,et al.  Delayed hyper‐enhancement of myocardium in hypertrophic cardiomyopathy with asymmetrical septal hypertrophy: Comparison with global and regional cardiac MR imaging appearances , 2004, Journal of magnetic resonance imaging : JMRI.

[14]  Comparison of contrast-enhanced MRI with iodine-123 BMIPP for detection of myocardial damage in hypertrophic cardiomyopathy. , 2005, AJR. American journal of roentgenology.

[15]  Yasuo Amano,et al.  Reduction in flow artifacts by using interleaved data acquisition in segmented balanced steady-state free precession cardiac MRI. , 2005, Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society.

[16]  J. Moon,et al.  Cardiovascular magnetic resonance and the evaluation of heart failure , 2005, Current cardiology reports.